Earth Science Tech, Inc. (ETST) reported its financial results for the three and nine months ended December 31, 2025, showing a revenue increase to $8.39 million for the quarter, up from $7.35 million in the same period last year. For the nine-month period, revenue rose to $26.20 million compared to $24.44 million in the prior year. The company achieved a gross profit of $6.40 million for the quarter, reflecting a significant increase from $5.09 million year-over-year, while the nine-month gross profit also improved to $19.21 million from $17.76 million.
In terms of expenses, ETST reported total expenses of $5.06 million for the three months ended December 31, 2025, compared to $4.86 million in the same quarter of 2024. Notably, salaries expense decreased to $2.93 million from $3.30 million, while advertising and marketing expenses increased significantly to $0.71 million from $0.35 million. The net income for the quarter was $0.91 million, a substantial rise from $0.21 million in the previous year, and for the nine-month period, net income reached $2.31 million, compared to $2.08 million in 2024.
ETST has made strategic advancements, including the acquisition of Mister Meds, which received full compounding licensure in March 2025. This acquisition is part of ETST's broader strategy to enhance its operational capabilities in the pharmaceutical sector. The company is also expanding its telemedicine services through Peaks Curative, which aims to provide nationwide services as it continues to pursue licensure in additional states. The company’s real estate subsidiary, Avenvi, is actively managing a growing portfolio, contributing to its diversified business model.
Operationally, ETST reported an increase in accounts receivable to $306,118 from $129,064 year-over-year, indicating a growing customer base. The company’s inventory also rose significantly to $1.09 million from $0.50 million, reflecting increased product availability. The total assets of ETST increased to $8.09 million as of December 31, 2025, compared to $7.07 million at the end of the previous fiscal period, while total liabilities decreased to $2.29 million from $3.22 million, indicating improved financial health.
Looking ahead, ETST remains focused on expanding its market presence and enhancing its product offerings. The company plans to continue its share repurchase program and invest in its subsidiaries to drive growth. With a strategic emphasis on operational optimization and market expansion, ETST aims to leverage its diversified business model to create long-term value for its shareholders.
About Earth Science Tech, Inc.
Earth Science Tech, Inc. is a diversified holding company specializing in pharmaceutical compounding, telemedicine, and real estate development. Its subsidiaries include licensed pharmacies, telehealth platforms, and real estate assets, serving healthcare providers and consumers. The company emphasizes operational efficiency, strategic acquisitions, and brand growth in regulated markets, offering customized health solutions, consumer products, and community support through its integrated business model.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.